Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Flutamide reduces hair growth better but has more side effects.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

The survey helps identify menstrual irregularities and excess male hormones, aiming to detect conditions like Polycystic Ovary Syndrome.

Finasteride discontinuation increases sperm count in men.

Finasteride may improve sperm count in subfertile men with low sperm count.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.

About 7% of Omani women visiting a gynecology clinic had polycystic ovarian syndrome, similar to rates in other countries.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Hair changes can indicate systemic diseases or medication effects.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Heavier birth weight may increase the risk of early hair graying in women.

PCOS significantly affects women's mental health, and more research is needed to develop effective treatments for these issues.